IUS Publications

Found 7 results
Filters: Author is Esma Bilajac  [Clear All Filters]
2023
E. Bilajac, Glamočlija, U., Osmanović, A., Mahmutovic, L., Sezer, A., Roca, S., Špirtović-Halilović, S., Salihović, M., Hromic-Jahjefendic, A., and Veljović, E., “Analysis of Antitumor Potential of Xanthene Compounds in Lymphoma Cells”, Croatica Chemica Acta, vol. 96, 2023.
K. Lundstrom, Hromic-Jahjefendic, A., and Bilajac, E., “COVID-19 signalome: Pathways for SARS-CoV-2 infection and impact on COVID-19 associated comorbidity”, Cellular Signaling, 2023.
K. Lundstrom, Hromic-Jahjefendic, A., and Bilajac, E., “COVID-19 signalome: Potential therapeutic interventions”, Cellular Signaling, vol. 103, 2023.
2022
E. Bilajac, Mahmutovic, L., Glamočlija, U., Osmanović, A., Hromic-Jahjefendic, A., Tambuwala, M. M., and Suljagic, M., “Curcumin Decreases Viability and Inhibits Proliferation of Imatinib-Sensitive and Imatinib-Resistant Chronic Myeloid Leukemia Cell Lines”, MDPI Metabolites, vol. 13, 2022.
E. Bilajac, Mahmutovic, L., Glamočlija, U., Osmanović, A., Hromic-Jahjefendic, A., Tambuwala, M., and Suljagic, M., “Curcumin Decreases Viability and Inhibits Proliferation of Imatinib-Sensitive and Imatinib-Resistant Chronic Myeloid Leukemia Cell Lines”, MDPI Metabolites, 2022.
E. Bilajac, Mahmutovic, L., Lundstrom, K., Glamočloja, U., Šutković, J., Sezer, A., and Hromic-Jahjefendic, A., “Viral Agents as Potential Drivers of Diffuse Large B-Cell Lymphoma Tumorigenesis”, MDPI Viruses, 2022.
2021
L. Mahmutovic, “Meet the Insidious Players: Review of Viral Infections in Head and Neck Cancer Etiology with an Update on Clinical Trials”, Microorganisms, vol. 9, 2021.